ALPMY
Price
$13.86
Change
-$0.05 (-0.36%)
Updated
Jan 30 closing price
Capitalization
25.07B
3 days until earnings call
Intraday BUY SELL Signals
DSNKY
Price
$18.20
Change
-$1.18 (-6.09%)
Updated
Jan 30 closing price
Capitalization
34.27B
81 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

ALPMY vs DSNKY

Header iconALPMY vs DSNKY Comparison
Open Charts ALPMY vs DSNKYBanner chart's image
Astellas Pharma
Price$13.86
Change-$0.05 (-0.36%)
Volume$94.74K
Capitalization25.07B
Daiichi Sankyo
Price$18.20
Change-$1.18 (-6.09%)
Volume$959.67K
Capitalization34.27B
ALPMY vs DSNKY Comparison Chart in %
ALPMY
Daily Signal:
Gain/Loss:
DSNKY
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
ALPMY vs. DSNKY commentary
Feb 01, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ALPMY is a Hold and DSNKY is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Feb 01, 2026
Stock price -- (ALPMY: $13.86 vs. DSNKY: $18.20)
Brand notoriety: ALPMY and DSNKY are both not notable
Both companies represent the Pharmaceuticals: Major industry
Current volume relative to the 65-day Moving Average: ALPMY: 88% vs. DSNKY: 238%
Market capitalization -- ALPMY: $25.07B vs. DSNKY: $34.27B
ALPMY [@Pharmaceuticals: Major] is valued at $25.07B. DSNKY’s [@Pharmaceuticals: Major] market capitalization is $34.27B. The market cap for tickers in the [@Pharmaceuticals: Major] industry ranges from $928.27B to $0. The average market capitalization across the [@Pharmaceuticals: Major] industry is $114.37B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ALPMY’s FA Score shows that 1 FA rating(s) are green whileDSNKY’s FA Score has 2 green FA rating(s).

  • ALPMY’s FA Score: 1 green, 4 red.
  • DSNKY’s FA Score: 2 green, 3 red.
According to our system of comparison, both ALPMY and DSNKY are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ALPMY’s TA Score shows that 3 TA indicator(s) are bullish while DSNKY’s TA Score has 3 bullish TA indicator(s).

  • ALPMY’s TA Score: 3 bullish, 5 bearish.
  • DSNKY’s TA Score: 3 bullish, 6 bearish.
According to our system of comparison, ALPMY is a better buy in the short-term than DSNKY.

Price Growth

ALPMY (@Pharmaceuticals: Major) experienced а -3.28% price change this week, while DSNKY (@Pharmaceuticals: Major) price change was -8.27% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Major industry was -0.61%. For the same industry, the average monthly price growth was +3.31%, and the average quarterly price growth was +14.38%.

Reported Earning Dates

ALPMY is expected to report earnings on Feb 04, 2026.

DSNKY is expected to report earnings on Apr 23, 2026.

Industries' Descriptions

@Pharmaceuticals: Major (-0.61% weekly)

The Major Pharmaceuticals industry includes companies that are involved in various processes of creating drugs to treat/prevent diseases. These companies engage in research, testing and manufacturing, as well as the distribution of pharmaceuticals into markets. Johnson & Johnson, Merck & Co., Inc., Pfizer Inc. and Novartis are among the largest companies in this category.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
DSNKY($34.3B) has a higher market cap than ALPMY($25.1B). ALPMY has higher P/E ratio than DSNKY: ALPMY (30.53) vs DSNKY (18.63). ALPMY YTD gains are higher at: 4.289 vs. DSNKY (-14.313). DSNKY has higher annual earnings (EBITDA): 400B vs. ALPMY (347B). DSNKY has more cash in the bank: 594B vs. ALPMY (296B). DSNKY has less debt than ALPMY: DSNKY (201B) vs ALPMY (741B). ALPMY (2.01T) and DSNKY (1.98T) have equivalent revenues.
ALPMYDSNKYALPMY / DSNKY
Capitalization25.1B34.3B73%
EBITDA347B400B87%
Gain YTD4.289-14.313-30%
P/E Ratio30.5318.63164%
Revenue2.01T1.98T101%
Total Cash296B594B50%
Total Debt741B201B369%
FUNDAMENTALS RATINGS
ALPMY vs DSNKY: Fundamental Ratings
ALPMY
DSNKY
OUTLOOK RATING
1..100
6850
VALUATION
overvalued / fair valued / undervalued
1..100
8
Undervalued
23
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
1003
PRICE GROWTH RATING
1..100
4286
P/E GROWTH RATING
1..100
9093
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ALPMY's Valuation (8) in the null industry is in the same range as DSNKY (23). This means that ALPMY’s stock grew similarly to DSNKY’s over the last 12 months.

ALPMY's Profit vs Risk Rating (100) in the null industry is in the same range as DSNKY (100). This means that ALPMY’s stock grew similarly to DSNKY’s over the last 12 months.

DSNKY's SMR Rating (3) in the null industry is significantly better than the same rating for ALPMY (100). This means that DSNKY’s stock grew significantly faster than ALPMY’s over the last 12 months.

ALPMY's Price Growth Rating (42) in the null industry is somewhat better than the same rating for DSNKY (86). This means that ALPMY’s stock grew somewhat faster than DSNKY’s over the last 12 months.

ALPMY's P/E Growth Rating (90) in the null industry is in the same range as DSNKY (93). This means that ALPMY’s stock grew similarly to DSNKY’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ALPMYDSNKY
RSI
ODDS (%)
Bearish Trend 3 days ago
70%
Bullish Trend 3 days ago
81%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
65%
Bullish Trend 3 days ago
74%
Momentum
ODDS (%)
Bearish Trend 3 days ago
64%
Bearish Trend 3 days ago
71%
MACD
ODDS (%)
Bearish Trend 3 days ago
67%
Bearish Trend 3 days ago
69%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
67%
Bearish Trend 3 days ago
74%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
63%
Bearish Trend 3 days ago
75%
Advances
ODDS (%)
Bullish Trend 7 days ago
65%
Bullish Trend 21 days ago
69%
Declines
ODDS (%)
Bearish Trend 5 days ago
68%
Bearish Trend 5 days ago
74%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
60%
Bearish Trend 3 days ago
79%
Aroon
ODDS (%)
Bullish Trend 3 days ago
69%
Bearish Trend 3 days ago
74%
View a ticker or compare two or three
Interact to see
Advertisement
ALPMY
Daily Signal:
Gain/Loss:
DSNKY
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
JPSV60.800.42
+0.70%
JPMorgan Active Small Cap Value ETF
IGA9.940.05
+0.51%
Voya Global Advantage AND Premium Opportunity Fund
ODHY10.02N/A
N/A
Obra Defensive High Yield ETF
PDT12.99-0.04
-0.31%
John Hancock Premium Dividend Fund
VYMI95.14-1.23
-1.28%
Vanguard Intl Hi Div Yld Idx ETF

ALPMY and

Correlation & Price change

A.I.dvisor indicates that over the last year, ALPMY has been loosely correlated with ALPMF. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if ALPMY jumps, then ALPMF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ALPMY
1D Price
Change %
ALPMY100%
-0.36%
ALPMF - ALPMY
38%
Loosely correlated
N/A
OPHLY - ALPMY
33%
Loosely correlated
-0.61%
CHGCY - ALPMY
22%
Poorly correlated
-0.07%
DSNKY - ALPMY
21%
Poorly correlated
-6.09%
OTSKY - ALPMY
20%
Poorly correlated
N/A
More

DSNKY and

Correlation & Price change

A.I.dvisor indicates that over the last year, DSNKY has been loosely correlated with CHGCY. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if DSNKY jumps, then CHGCY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DSNKY
1D Price
Change %
DSNKY100%
-6.09%
CHGCY - DSNKY
38%
Loosely correlated
-0.07%
OTSKY - DSNKY
37%
Loosely correlated
N/A
DSKYF - DSNKY
34%
Loosely correlated
-3.32%
BIIB - DSNKY
23%
Poorly correlated
+2.11%
ALPMY - DSNKY
21%
Poorly correlated
-0.36%
More